Видео ютуба по тегу Humacyte Human Acellular Vessel

Revolutionary Vascular Repair with Humacyte's HAV: A Medical Breakthrough #RegenerativeMedicine
Revolutionary Vascular Repair with Humacyte's HAV: A Medical Breakthrough #RegenerativeMedicine
False aneurysm from alloprosthesithe Humacyte human acellular vessels. Treatment by trombin
False aneurysm from alloprosthesithe Humacyte human acellular vessels. Treatment by trombin
Breakthroughs in Vascular Surgery
Breakthroughs in Vascular Surgery
Technological advances in human acellular vessels
Technological advances in human acellular vessels
Global Kidney Voices™: Kidney Patients Driving Global Innovation & Independence (Humacyte)
Global Kidney Voices™: Kidney Patients Driving Global Innovation & Independence (Humacyte)
Durham company growing blood vessels from human cells
Durham company growing blood vessels from human cells
The development of human acellular vessels and its advantages
The development of human acellular vessels and its advantages
Human acellular vessels in coronary artery disease
Human acellular vessels in coronary artery disease
Field Notes Ep. 8 | Exploring Potential Improvements in Dialysis Access with Dr. Laura Nikalson
Field Notes Ep. 8 | Exploring Potential Improvements in Dialysis Access with Dr. Laura Nikalson
Humacyte: Saving lives with lab-grown blood vessels in conflict zones
Humacyte: Saving lives with lab-grown blood vessels in conflict zones
Humacyte's Bioengineered Vessel: A Viable Solution for Hemodialysis Access
Humacyte's Bioengineered Vessel: A Viable Solution for Hemodialysis Access
GMO Dialogues | Humacyte and its humanitarian aid to Ukraine with Laura Niklason, MD, PhD
GMO Dialogues | Humacyte and its humanitarian aid to Ukraine with Laura Niklason, MD, PhD
Overcoming hurdles associated with commercializing advanced therapies
Overcoming hurdles associated with commercializing advanced therapies
Dirty Cheap Stock That will make you Money in 2025- Humacyte, Inc.$HUMA (NASDAQ: HUMA) Stock
Dirty Cheap Stock That will make you Money in 2025- Humacyte, Inc.$HUMA (NASDAQ: HUMA) Stock
Humacyte’s Engineered Blood Vessels: A Game-Changer for Hemodialysis Access? | 2-Year Study Results
Humacyte’s Engineered Blood Vessels: A Game-Changer for Hemodialysis Access? | 2-Year Study Results
Humacyte, Inc. (NASDAQ: HUMA)
Humacyte, Inc. (NASDAQ: HUMA)
The future of small-diameter human acellular vessels
The future of small-diameter human acellular vessels
Humacyte's Engineered Vessel for Hemodialysis: 2-Year Results & Patient Benefits
Humacyte's Engineered Vessel for Hemodialysis: 2-Year Results & Patient Benefits
Bioenginnering Human Tissue With Humacyte's Dr. Heather Prichard
Bioenginnering Human Tissue With Humacyte's Dr. Heather Prichard